Department of Gastroenterology, Changhai Hospital of Second Military Medical University, Shanghai, China.
Gastroenterology. 2012 Apr;142(4):762-72. doi: 10.1053/j.gastro.2011.12.050. Epub 2012 Jan 11.
BACKGROUND & AIMS: There have been inconsistent results published about the relationship between excess body weight, expressed as increased body mass index (BMI), and risk of colorectal adenoma (CRA). We conducted a meta-analysis to explore this relationship. We focused on whether the relationship varied based on the sex of the study subjects, study design, features of the polyps, or potential confounders, including alcohol use, nonsteroidal anti-inflammatory drug use, smoking, and exercise.
We identified studies by performing a literature search of Medline, EMBASE, and ISI Web of Science through July 31, 2011, and by searching the reference lists of pertinent articles. We analyzed 36 independent studies, which included 29,860 incident cases of CRA. Summary relative risks with their 95% confidence intervals (CIs) were calculated with a random-effects model. Between-study heterogeneity was assessed using Cochran's Q statistic and I(2) analyses.
Overall, a 5-unit increase in BMI (calculated as kg/m(2)) increased the risk for CRA (summary relative risk = 1.19; 95% CI: 1.13-1.26), although there was a high level of heterogeneity among studies (P(heterogeneity) < .001; I(2) = 76.8%). Subgroup analyses revealed that the increased risk of CRA in obese individuals was independent of race, geographic location, study design, sex, adenoma progression, and confounders. The association between increased BMI and risk for CRA was stronger for colon than rectal adenoma.
Based on a meta-analysis, increased BMI increases the risk for colon but not rectal adenoma. Unlike colorectal cancer, there is no sex difference in the relationship between increased BMI and risk of CRA.
关于超重(表现为体重指数增加)与结直肠腺瘤(CRA)风险之间的关系,已有不一致的研究结果发表。我们进行了一项荟萃分析来探讨这种关系。我们专注于这种关系是否基于研究对象的性别、研究设计、息肉特征或潜在混杂因素(包括饮酒、非甾体抗炎药使用、吸烟和运动)而有所不同。
我们通过对 Medline、EMBASE 和 ISI Web of Science 进行文献检索,于 2011 年 7 月 31 日之前确定了研究,并检索了相关文章的参考文献列表。我们分析了 36 项独立研究,其中包括 29860 例 CRA 新发病例。采用随机效应模型计算了汇总相对风险及其 95%置信区间(CI)。采用 Cochran's Q 统计量和 I(2)分析评估研究间的异质性。
总体而言,BMI 每增加 5 个单位(以 kg/m(2)计算),CRA 的风险就会增加(汇总相对风险=1.19;95%CI:1.13-1.26),尽管研究间存在高度异质性(P(异质性) <.001;I(2) = 76.8%)。亚组分析表明,肥胖者 CRA 的风险增加与种族、地理位置、研究设计、性别、腺瘤进展和混杂因素无关。BMI 增加与 CRA 风险之间的关联在结肠腺瘤中比直肠腺瘤更强。
基于荟萃分析,BMI 增加会增加结肠腺瘤但不会增加直肠腺瘤的风险。与结直肠癌不同,BMI 增加与 CRA 风险之间的关系在性别方面没有差异。